lower inventory levels,
and increased 5% for the 2007 first nine months. The increase in
Pharmaceuticals net revenue was offset, in part, by lower sales of
Inderal(R) LA due to generic competition. Alliance revenue decreased 12% to
$314 million for the 2007 third quarter due to lower alliance revenue
associated with sales of the CYPHER stent and Altace. For the 2007 first
nine months, alliance revenue increased slightly to $973 million due to
higher sales of Enbrel in the United States and Canada, which were
partially offset by lower alliance revenue associated with sales of the
CYPHER stent and Altace. Excluding the favorable impact of foreign
exchange, worldwide Pharmaceuticals net revenue increased 7% for the 2007
third quarter and 8% for the 2007 first nine months.
Consumer Healthcare
Worldwide Consumer Healthcare net revenue increased 8% for the 2007
third quarter due primarily to an increase in sales of Advil(R), Advil(R)
PM, and Caltrate(R). Net revenue increased 7% for the 2007 first nine
months due primarily to an increase in sales of Centrum(R), Advil, Advil
PM, and Caltrate. Excluding the favorable impact of foreign exchange,
worldwide Consumer Healthcare net revenue increased 4% for the 2007 third
quarter and first nine months.
Animal Health
Worldwide Animal Health net revenue increased 11% for the 2007 third
quarter due to higher sales of livestock, poultry and companion animal
products, which included sales of our recently launched ProMeris(R) flea
and tick products. Net revenue for the 2007 first nine months increased 8%
due to higher sales of livestock, poultry, companion animal and equine
products. Excluding the favorable impact of foreign exchange, worldwide
Animal Health net revenue increased 6% for the 2007 third quarter and 4%
for the 2007 first nine months.
Results of Operations
The comparative results of operations are as follows:
(In thousands except per share amounts)
'/>"/>
SOURCE Wyeth Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Related medicine news :1.
Wyeth Launches Vaccine for Pneumococcal Disease in India2.
Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy3.
Wyeth Pharma Wins Law Suit4.
Verdict Against Wyeth Pharma in Prempro Case5.
FDA Approves Wyeths Oral Contraceptive Lybrel6.
Autopsy reports could be valuable and informative7.
China reports declining number of SARS Cases8.
Russia Reports First SARS Case9.
Research reports that c-section deliveries are rising
10.
Jharkhand reports 13,000 Malaria cases 11.
Uganda Reports Failure To Contain Sleeping Sickness